LUMOS PHARMA, INC. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Lumos Pharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2024.
  • Lumos Pharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$5K, a 98.4% increase year-over-year.
  • Lumos Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$576K, a 29.8% increase from 2022.
  • Lumos Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$821K, a 328% decline from 2021.
  • Lumos Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$192K, a 356% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$5K +$304K +98.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 -$309K -$291K -1617% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 -$18K +$148K +89.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q1 2021 -$166K -$166K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $0 +$46K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 -$46K +$178K +79.5% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q1 2018 -$224K +$4K +1.75% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 -$228K -$199K -686% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2016 -$29K -$14.7M -100% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q1 2015 $14.6M -$14M -48.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q1 2014 $28.6M -$20.4M -41.6% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-08-24
Q1 2013 $49M +$48.9M +62677% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 $78K +$119K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q1 2011 -$41K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.